Parental perceptions of the COVID-19 vaccine for 5- to 11-year-old children: Focus group findings from Worcester Massachusetts-Reference-Cited by-同舟云学术

Parental perceptions of the COVID-19 vaccine for 5- to 11-year-old children: Focus group findings from Worcester Massachusetts

Published:2022-09-09 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Goulding Melissa¹^ORCID,Ryan Grace W.¹,Minkah Princilla¹,Borg Amy¹,Gonzalez Maricelis²,Medina Nelly³,Suprenant Pamela⁴,Rosal Milagros C.¹,Lemon Stephenie C.¹

Affiliation:

1. Division of Preventive and Behavioral Medicine, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, USA

2. El Buen Samaritano Food Program Inc, Worcester, MA, USA

3. Parents Union of Massachusetts, Worcester, MA, USA

4. YMCA of Central Massachusetts, Worcester, MA, USA

Funder

National Center for Advancing Translational Sciences

National Cancer Institute

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2120721

Reference39 articles.

1. CDC. COVID data tracker. Centers for disease control and prevention; 2020 Mar 28 [accessed 2021 Dec 7]. https://covid.cdc.gov/covid-data-tracker.

2. COVID-19 hospitalizations; [accessed 2022 Mar 8]. https://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html.

3. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021

4. Commissioner O of the FDA authorizes Pfizer-BioNtech COVID-19 vaccine for emergency use in children 5 through 11 years of age. FDA; 2021 Oct 29 [accessed 2021 Dec 7]. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age.

5. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19;Frontiers in Public Health;2024-08-08

2. Factors Influencing Pediatric COVID-19 Vaccination Uptake: A Quantitative Investigation in the Philippines;2024-08-02

3. Implementation of social needs screening for minoritized patients newly diagnosed with breast cancer: a mixed methods evaluation in a pragmatic patient navigation trial;BMC Health Services Research;2024-07-09

4. Exploring the relationship between vaccine hesitancy and mothers’ perspectives on COVID-19 vaccines for children ages 5–11 years during the omicron predominant period 2021–2022: a qualitative study;Frontiers in Public Health;2024-07-08

5. COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients;Canadian Journal of Infectious Diseases and Medical Microbiology;2024-05-15